Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

Abstract. Recently, the European Medicines Agency approved the use of the vasopressin V2 receptor antagonist tolvaptan to slow the progression of cyst developm

Bibliographic Details

Main Authors:	Gansevoort, Ron T. (Author) , Arici, Mustafa (Author) , Benzing, Thomas (Author) , Birn, Henrik (Author) , Capasso, Giovambattista (Author) , Covic, Adrian (Author) , Devuyst, Olivier (Author) , Drechsler, Christiane (Author) , Eckardt, Kai-Uwe (Author) , Emma, Francesco (Author) , Knebelmann, Bertrand (Author) , Le Meur, Yannick (Author) , Massy, Ziad A. (Author) , Ong, Albert C. M. (Author) , Ortiz, Alberto (Author) , Schaefer, Franz (Author) , Torra, Roser (Author) , Vanholder, Raymond (Author) , Więcek, Andrzej (Author) , Zoccali, Carmine (Author) , Van Biesen, Wim (Author)
Format:	Article (Journal)
Language:	English
Published:	29 January 2016
In:	Nephrology, dialysis, transplantation Year: 2016, Volume: 31, Issue: 3, Pages: 337-348
ISSN:	1460-2385
DOI:	10.1093/ndt/gfv456
Online Access:	Verlag, Volltext: https://doi.org/10.1093/ndt/gfv456 Verlag, Volltext: https://academic.oup.com/ndt/article/31/3/337/2460159
Author Notes:	Ron T. Gansevoort, Mustafa Arici, Thomas Benzing, Henrik Birn, Giovambattista Capasso, Adrian Covic, Olivier Devuyst, Christiane Drechsler, Kai-Uwe Eckardt, Francesco Emma, Bertrand Knebelmann, Yannick Le Meur, Ziad A. Massy, Albert C. M. Ong, Alberto Ortiz, Franz Schaefer, Roser Torra, Raymond Vanholder, Andrzej Więcek, Carmine Zoccali and Wim Van Biesen